A novel, oral 5HT3 partial agonist, DDP733, improves overall response in patients with irritable bowel syndrome and constipation (IBS-c): A randomized, double blind, placebo-controlled, parallel-group, dose-ranging study Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Paterson, William G
  • Ford, David
  • Ganguli, Subhas Chandra
  • Reynolds, Richard P
  • Pliamm, Lew
  • O'Mahony, Michael
  • Pare, Pierre
  • Nurbhai, Suhail
  • Feagan, Brian
  • Landau, Steven B

publication date

  • April 1, 2008